24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825

Medical Disorders
Resources
Basic InformationLookupsLatest News
Buyer Beware When Purchasing Medical Test StripsEgg Allergy? Don't Let That Stop You From Getting VaccinatedGene Therapy Might Prove a Cure for 'Bubble Boy' DiseaseTwo Lives Saved in Rare 'Paired' Liver DonationYour Life Span May Be Foretold in Your Heart BeatsHealth Tip: Stopping NosebleedsKids Can Get UTIs, TooIs a New Remedy for Body Odor on the Horizon?Why More Patients Are Surviving an AneurysmCommon Diabetes Drug May Also Shield Kidneys, HeartIsraeli Team Announces First 3D-Printed Heart Using Human Cells'Added Sugars' Label on Foods Could Save Many LivesCPAP Brings Longer Life for Obese People With Sleep Apnea: StudyYoung Athletes Need to Be Sidelined After Bout of MonoPre-Cut Melons at Kroger, Walmart, Other Stores May Carry SalmonellaCDC Says Ground Beef Is Source of E. coli Outbreak, Cases Rise to 109AHA News: Is Yoga Heart-Healthy? It's No Stretch to See Benefits, Science SuggestsFDA Orders Label Warning on Alcohol Use With 'Female Viagra'Could Treating Gut Bacteria Help Ease Autism Symptoms?Hospital Privacy Curtains Could Be Breeding Ground for GermsItchy Skin Common Alongside Kidney DiseaseMany Misdiagnosed With MSVehicle Exhaust Drives Millions of New Asthma Cases AnnuallyNFL Retirees Help Scientists Develop Early Test for Brain Condition CTEMigraine Pain Linked to Raised Suicide RiskMore Time Spent in Sports, Faster Healing From ConcussionHealth Tip: Thermometer OptionsStill No Source as E. Coli Outbreak Grows to 96 Cases Across 5 States: CDCClimate Change Could Worsen Sneezin' SeasonEvenity Approved for Osteoporotic WomenNYC Declares Public Health Emergency Over Brooklyn Measles OutbreakInsurers' Denials of Opioid Coverage Spurs CDC to Clarify GuidelinesImmune-Targeted Treatment Might Help Prevent Peanut Allergy CrisesCluster of Dangerous Antibiotic-Resistant E. Coli Infection Spotted in NYCHealth Tip: Managing Chronic MigrainesFor One Man, Too Much Vitamin D Was DisastrousCDC Investigates Mystery E. Coli Outbreak Affecting 5 StatesBlacks Live Longer, Not Necessarily Better, With ALSIs It Heartburn or Something Else?Lungs, Hearts Infected With Hepatitis C Still OK for TransplantUnhealthy Diets May Be World's Biggest KillerSevere 'Mono' Infection May Raise Risk for Chronic Fatigue SyndromeUnder-the-Tongue Allergy Pills Replacing Shots for ManyFish Slime Could Hold Key to Beating 'Superbug' InfectionsPet Hedgehogs Still Spreading Salmonella, CDC WarnsCimzia Approved for Inflammatory ArthritisSpring Is the Sneezing SeasonU.S. Flu Season Ebbing, but Cases Still Widespread: CDCLab-Grown Blood Vessels Could Be Big Medical AdvanceClimate Change Will Aid Spread of Disease-Bearing Mosquitoes
Questions and AnswersLinks
Related Topics

Diabetes

First Generic Version of Advair Diskus Approved for Asthma, COPD

HealthDay News
by -- Scott Roberts
Updated: Jan 31st 2019

THURSDAY, Jan. 31, 2019 (HealthDay News) -- The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the U.S. Food and Drug Administration.

It can now be used to treat children aged 4 or older with asthma and adults with asthma or chronic obstructive pulmonary disease (COPD).

"People living with asthma and COPD know too well the critical importance of having access to the treatment they need to feel better. Today's approval will bring more competition to the market which will ultimately benefit the patients who rely on this drug, " said Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research.

More than 26 million people in the United States have asthma, and about 7 million are children, the agency said in a news release. COPD is a chronic lung disease that triggers coughing, chest tightness and makes it hard to breathe. It may worsen over time, the FDA said.

The agency said it requires data showing that generic drug devices meet the agency's rigorous approval standards to ensure they are as safe and effective as their brand-name counterparts.

The most common side effects from the inhaler's use in asthmatics include upper-respiratory tract infection, swelling in the back of the throat, hoarse voice, bronchitis, cough, headaches, nausea and vomiting. For the treatment of COPD, the most common side effects are pneumonia, throat irritation, hoarse voice, viral respiratory infection, headaches and musculoskeletal pain.

Approval of the generic Advair Diskus was given to Mylan, based in Canonsburg, Pa. The brand-name drug/device is produced by GlaxoSmithKline.

More information

Visit the U.S. National Heart, Lung, and Blood Institute for more on asthma.